Candida utilis as an emerging rare cause of septicemia among neonates and children in Western Uttar Pradesh: A case series

Document Type : Short Communication

Authors

1 Department of Microbiology, UPUMS, Saifai, Etawah, Uttar Pradesh, India

2 Department of Paediatrics, UPUMS, Saifai, Etawah, Uttar Pradesh, India

3 Department of Microbiology, RMLIMS, Lucknow, Uttar Pradesh, India

Abstract

Background and Purpose: Candida utilis is a recently emerging nosocomial fungal pathogen. Candidemia is the 4th most prevalent cause of Bloodstream Infections with mortality rates varying from 5% to 71%.
Materials and Methods: This was a retrospective study conducted at Uttar Pradesh University of Medical Sciences, Saifai (Etawah), Uttar Pradesh from September 2023 to February 2024. Rapid identification was done by VITEK® 2 (BioMérieux, France) and 18 out of 20 C. utilis cases were verified by Matrix Assisted Laser Desorption Ionization – Time of flight mass Spectrometry (MALDI–TOF MS) (BioMerieux, France). Susceptibility testing was conducted by VITEK® 2 appropriate Card. 
Results: Candida utilis was mainly observed between 0 – 9-month-olds except one case of 11 years old. The extended Intensive care unit stay and prior antibiotic use were common risk factors in all cases. They were pan susceptible to each of the tested antifungal medications. 6 Out of 10 showed positive clinical response after antifungal treatment.
Conclusion: Early identification and prompt treatment favors a good clinical outcome. The primary objective of the current research was to elaborate on the speciation, incidence, and Antifungal susceptibility testing of C. utilis at a tertiary care center.
 

Keywords

Main Subjects

Current Medical Mycology

Articles in Press, Accepted Manuscript
Available Online from 13 July 2024

Files

History

  • Receive Date: 09 April 2024
  • Revise Date: 19 June 2024
  • Accept Date: 13 July 2024
  • First Publish Date: 13 July 2024

Share

How to cite

Statistics